Bioorthogonal click chemistry is being used in patients to help target cancer medicines and diagnostic imaging agents
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Change history
20 July 2023
In the version of this article initially published, Carolyn Bertozzi was described as being at Stanford during development of the copper-free click reaction; she was at University of California, Berkeley, as is now reflected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peplow, M. ‘Clicked’ drugs: researchers prove the remarkable chemistry in humans. Nat Biotechnol 41, 883–885 (2023). https://doi.org/10.1038/s41587-023-01860-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-023-01860-2